Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma [2]

Izidore S. Lossos; Daniel Morgensztern; Marcelo Blaya; Alvaro Alencar; Denise Pereira; Joseph Rosenblatt

doi:10.1080/10428190701457949

Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma [2]

Izidore S. Lossos, Daniel Morgensztern, Marcelo Blaya, Alvaro Alencar, Denise Pereira, Joseph Rosenblatt

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1630-1632
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	48
Issue number	8
DOIs	https://doi.org/10.1080/10428190701457949
State	Published - Aug 2007

Access to Document

10.1080/10428190701457949

Cite this

@article{1e374af580a94621bed61b3443127d10,

title = "Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma [2]",

author = "Lossos, {Izidore S.} and Daniel Morgensztern and Marcelo Blaya and Alvaro Alencar and Denise Pereira and Joseph Rosenblatt",

note = "Funding Information: This work was supported by RO1 CA109335 from the United States Public Health Service, National Institutes of Health (ISL) and the Dwoskin Family Foundation.",

year = "2007",

month = aug,

doi = "10.1080/10428190701457949",

language = "English",

volume = "48",

pages = "1630--1632",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

number = "8",

}

TY - JOUR

T1 - Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma [2]

AU - Lossos, Izidore S.

AU - Morgensztern, Daniel

AU - Blaya, Marcelo

AU - Alencar, Alvaro

AU - Pereira, Denise

AU - Rosenblatt, Joseph

N1 - Funding Information: This work was supported by RO1 CA109335 from the United States Public Health Service, National Institutes of Health (ISL) and the Dwoskin Family Foundation.

PY - 2007/8

Y1 - 2007/8

UR - http://www.scopus.com/inward/record.url?scp=34547969504&partnerID=8YFLogxK

U2 - 10.1080/10428190701457949

DO - 10.1080/10428190701457949

M3 - Letter

C2 - 17701596

AN - SCOPUS:34547969504

SN - 1042-8194

VL - 48

SP - 1630

EP - 1632

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 8

ER -

Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma [2]

Access to Document

Other files and links

Cite this